Health Condition 1: null- neurologically impaired
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients of both genders, age group of 18 to 60 years, ASA grade I â?? III, will be included in this study. Hess and hunt grade I â?? IV.
Exclusion criteria
Exclusion criteria: Patients with severely impaired left ventricular function (EF 18), with renal impairment, with liver impairment, H/O recent myocardial infarction (within 6 weeks), H/O cardiac surgery (within previous three months), patients having H/O repeated coronary surgery, having associated heart block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study the cardioprotective role of sevoflurane and its comparison to propofol during aneurysm clipping surgery. 2.To study cardiac stress during triple-H therapy and comparison between two anaesthetic techniques.Timepoint: intraoperative and postoperative 3-14days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To study the cardiac injury in patients of aneurysmal subarachnoid haemorrhage after surgery in the background of hemodynamic state of patient. 2.To study the effect of subarachnoid haemorrhage on heart measured with the help of cardiac enzymes and vital parameters. 3.To compare patient outcome between propofol and sevoflurane as well as with and without Triple H therapy.Timepoint: intraoperative and postoperative day 3-14days | — |
Countries
India
Contacts
Sanjay Gandhi Post Graduate Institute of Medical Sciences